290 related articles for article (PubMed ID: 15265913)
1. MHC class I-independent recognition of NK-activating receptor KIR2DS4.
Katz G; Gazit R; Arnon TI; Gonen-Gross T; Tarcic G; Markel G; Gruda R; Achdout H; Drize O; Merims S; Mandelboim O
J Immunol; 2004 Aug; 173(3):1819-25. PubMed ID: 15265913
[TBL] [Abstract][Full Text] [Related]
2. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
4. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of natural killer cell surface receptors.
Radaev S; Sun PD
Annu Rev Biophys Biomol Struct; 2003; 32():93-114. PubMed ID: 12471063
[TBL] [Abstract][Full Text] [Related]
6. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
7. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope.
Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J
Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823
[TBL] [Abstract][Full Text] [Related]
8. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule.
Fan QR; Garboczi DN; Winter CC; Wagtmann N; Long EO; Wiley DC
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7178-83. PubMed ID: 8692965
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I.
Maenaka K; Juji T; Stuart DI; Jones EY
Structure; 1999 Apr; 7(4):391-8. PubMed ID: 10196125
[TBL] [Abstract][Full Text] [Related]
10. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors.
Boyington JC; Sun PD
Mol Immunol; 2002 May; 38(14):1007-21. PubMed ID: 11955593
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
12. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
13. Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.
Markel G; Seidman R; Besser MJ; Zabari N; Ortenberg R; Shapira R; Treves AJ; Loewenthal R; Orenstein A; Nagler A; Schachter J
PLoS One; 2009; 4(5):e5597. PubMed ID: 19440333
[TBL] [Abstract][Full Text] [Related]
14. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
Lian RH; Freeman JD; Mager DL; Takei F
J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
[TBL] [Abstract][Full Text] [Related]
15. Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides.
Betser-Cohen G; Katz G; Gonen-Gross T; Stern N; Arnon TI; Achdout H; Gazit R; Mandelboim O
J Immunol; 2006 Jun; 176(11):6762-9. PubMed ID: 16709835
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex.
Fan QR; Long EO; Wiley DC
Nat Immunol; 2001 May; 2(5):452-60. PubMed ID: 11323700
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
[TBL] [Abstract][Full Text] [Related]
19. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.
Valés-Gómez M; Reyburn HT; Erskine RA; Strominger J
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14326-31. PubMed ID: 9826699
[TBL] [Abstract][Full Text] [Related]
20. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3.
Radaev S; Rostro B; Brooks AG; Colonna M; Sun PD
Immunity; 2001 Dec; 15(6):1039-49. PubMed ID: 11754823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
